Tilray Brands, Inc.

TSX:TLRY.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$3.23 -1.19%

-$0.08 today

Market cap
$477.35M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $0.49High $21.57

Volume 0.86M

Average 0.64M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$94.60M

FY 2025 · Annual

Investing Cash Flow

-$46.72M

FY 2025 · Annual

Financing Cash Flow

$133.51M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Net Income(336.01M)(434.13M)(1.44B)(222.4M)(2.18B)
Depreciation & Amortization67.83M154.59M130.15M126.91M133.49M
Deferred Income Tax(24.87M)(27.54M)(31.95M)(38.87M)(121.02M)
Stock-Based Compensation17.35M35.99M39.6M31.77M24.29M
Change in Working Capital(50.94M)(91.77M)14.4M(8.87M)(62.56M)
Accounts Receivables(23.51M)(5.84M)4.17M(6.58M)(17.8M)
Inventory(35.29M)(45.75M)(12.93M)(15.58M)(13.56M)
Accounts Payables14.5M(44.65M)20.04M00
Other Working Capital(6.64M)4.47M3.14M(8.87M)(31.2M)
Other Non-Cash Items281.92M185.59M1.3B80.56M2.11B
Operating Cash Flow(44.72M)(177.26M)7.91M(30.91M)(94.6M)
Capital Expenditures(38.87M)(34.06M)(20.8M)(29.25M)(32.92M)
Acquisitions (Net)66.61M326K(26.72M)(52.12M)(18.11M)
Purchases of Investments6.61M0(241.9M)00
Sales of Investments8.43M0289.42M00
Other Investing Activities3.33M12.21M(285.11M)209.72M4.31M
Investing Cash Flow46.11M(21.53M)(285.11M)128.35M(46.72M)
Debt Repayment45.51M(123.55M)(58.25M)(83.81M)(26.14M)
Common Stock Issued102.55M262.51M129.59M8.62M161.19M
Common Stock Repurchased0(8.69M)(1.19M)00
Dividends Paid0(7.48M)000
Other Financing Activities(23.75M)0(804.41K)0(1.54M)
Financing Cash Flow124.31M128.2M70.16M(75.19M)133.51M
Effect of Forex Changes2.12M(1.96M)(2.23M)(549K)1.14M
Net Change in Cash127.82M(72.56M)(209.28M)21.71M(6.67M)
Free Cash Flow(83.59M)(211.33M)(12.89M)(60.15M)(127.52M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$2.2B
+ D&A$133.5M
+ Stock-Based Comp$24.3M
- Deferred Tax-$121.0M
- Working Capital-$62.6M
+ Other Non-Cash$2.1B
= Operating Cash Flow-$94.6M
- Capex-$32.9M
= Free Cash Flow-$127.5M

Analysis

FY2025 free cash flow is -$127.5M. FCF conversion is 5.8% of net income. Operating cash flow was -$94.6M, with capex of -$32.9M. The largest bridge item is Other Non-Cash at $2.1B.

Recent Filings

Recent regulatory filings

No filings found.

Does TLRY.TO generate free cash flow?

Tilray Brands, Inc. (TLRY.TO) generated -$127.52M of free cash flow in fiscal 2025.

How much operating cash flow does TLRY.TO produce?

Operating cash flow was -$94.60M, before capital expenditures of $32.92M.